Halozyme Therapeutics HALO

$ 45.45 -0.69%

Quarterly report 2024-Q3
added 10-31-2024

Halozyme Therapeutics Cash and Cash Equivalents 2011-2024 | HALO

Annual Cash and Cash Equivalents Halozyme Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
118 M	234 M	119 M	148 M	120 M	57.9 M	169 M	66.8 M	43.3 M	61.4 M	27.4 M	99.5 M	52.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
234 M	27.4 M	101 M

Quarterly Cash and Cash Equivalents Halozyme Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
154 M	188 M	165 M	118 M	274 M	221 M	96.9 M	234 M	148 M	91.4 M	118 M	119 M	492 M	447 M	499 M	148 M	148 M	148 M	148 M	120 M	120 M	120 M	120 M	57.9 M	57.9 M	57.9 M	57.9 M	169 M	169 M	169 M	169 M	66.8 M	66.8 M	66.8 M	66.8 M	43.3 M	43.3 M	43.3 M	43.3 M	61.4 M	61.4 M	61.4 M	61.4 M	27.4 M	27.4 M	27.4 M	27.4 M	99.5 M	99.5 M	99.5 M	99.5 M	52.4 M	52.8 M	52.8 M	52.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
499 M	27.4 M	123 M